Parallel Advisors, LLC Mirum Pharmaceuticals, Inc. Call Options Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding MIRM
# of Institutions
216Shares Held
53.7MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$290 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$202 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$123 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$115 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...